Clinical Trial Update: Intermediate Size Expanded Access Protocol Using Autologous HB-adMSCs for the Treatment of Parkinson's Disease

View source ↗

Summary

This document provides an update on an expanded-access protocol using autologous HB-adMSCs for Parkinson's disease, and notes that the study is no longer availa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• HB-adMSCs (autologous adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Hope Biosciences Research Foundation | Conditions: Parkinson Disease | Status: NO_LONGER_AVAILABLE